Innovation in Biological Indicator Evaluator Resistometer Vessel Technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Innovation in Biological Indicator Evaluator Resistometer Vessel Technology
The authors examine advances in the design and the application of biological indicator evaluator resistometer vessels used to measure the resistance of bacterial spores in monitoring sterilization processes.


Pharmaceutical Technology


Materials and methods


Figure 4
Resistometers . The Fedegari-manufactured resistometer is a model FOB 3 steam sterilizer (140 L) fitted with a device that allows the rapid insertion and removal of BIs into the chamber while charged and under pressure (see Figure 4). The device consists of a loading chamber, a guiding tube through the main chamber, and an exit chamber. The loading chamber is positioned on top of the resistometer. The biological indicators are gravity-fed through the vessel by the precise coordination of the series of valves. The system is computer controlled and allows the operator to program the exposure time. The system is capable of running prevacuum cycles by evacuation of the loading chamber before insertion of the BIs into the main chamber. A Kaye Digistrip datalogger using 10 thermocouples was used to monitor the chamber temperature.

The Steris (Joslyn)-manufactured resistometers (model SB-001 and model JS-BIER-STM, Steris Corp., Mentor, OH) meet the performance requirements as described in ANSI/AAMI/ISO 18472:2006. Only the load probe of the resistometers was used to monitor chamber temperature.


Table I. Description of biological indicators (BIs).
Parametric analysis. In each resistometer, exposures were performed in triplicate at temperatures from 121 to 129 C. Parametric data collected from these cycles were analyzed using the ANSI/AAMI/ISO standard as guidance.


Figure 5
Biological indicators . Three types of BIs—spore strip, self-contained, and glass ampul—from three manufacturers were used (see Table I). Spore-strip BIs consisted of Geobacillus stearothermophilus spores inoculated onto paper carriers and packaged in glassine envelopes. Self-contained BIs consisted of G. stearothermophilus spores inoculated onto paper carriers placed into a thermoplastic vial that serves as a culture tube. A small glass ampul containing sterile culture medium and color indicator also was in the vial. Glass-ampul BIs consisted of G. stearothermophilus spores suspended in liquid culture medium and sealed inside a small, thin-walled, pharmaceutical-grade glass ampul. BIs were loaded into a cassette (see Figure 5) before insertion into the chamber. Upon completion of the cycle, the cassette was removed from the chamber.

D and Z value analysis. Spore strip survivor curve. In the Fedegari and Steris (JS-BIER-STM) resistometers, D 121-values were determined (in triplicate) on the spore strip BIs by the survivor-curve method according to ISO 11138 (2). The survivor-curve method involves subjecting the BIs to a series of incremental exposure times followed by enumeration of the surviving spores through the performance of a population assay. This method was chosen for the simplest BIs to evaluate the linearity of the curve in each resistometer. Testing was as follows:

  • BI lot# S1—D 121-value determined in triplicate in Fedegari resistometer
  • BI lot# S1—D 121-value determined in triplicate in Steris (JS-BIER-STM) resistometer.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here